http://www.anikatherapeutics.com
Anika Therapeutics, Inc. Company Intro
Anika Therapeutics is recognized worldwide as a pioneer in hyaluronic acid (HA) therapeutic products for tissue protection, healing and repair. Anika’s HA products are used in joint health therapies, , ophthalmic surgery, anti-adhesive surgical applications, and as a dermal filler in aesthetic dermatology. Found throughout the body, HA enhances joint function, protects and lubricates soft tissues and supports skin structure and elasticity.
Industry
Healthcare
Anika Therapeutics, Inc. Headquaters
32 Wiggins Avenue
Bedford,01730
United States
Anika Therapeutics, Inc. Share price
22 Oct 2020 01:06 GMT
$35.98
-0.15 (-0.42 %)
Anika Therapeutics, Inc. Market cap
$509.051 M
WMC RANKING
2020
Anika Therapeutics, Inc. # 46
BiotechnologyLatest Anika Therapeutics, Inc. News
22 Oct 2020
Dermal Fillers and Botulinum Toxin Market Size, Share, Scope ...
Anika Therapeutics; Inc. LG Life Sciences; Suneva Medical; Inc. Hyaltech; Speciality European Pharma; HUGEL; Inc. Grex Pharma SaS; Daewoong ...
22 Oct 2020
High Viscosity Tissue Adhesives Market 2020 Research Key Players, Industry Overview by 2026 : Pfizer Inc., Cryolife Inc., B. Braun Corporation, Johnson and Johnson, Cardinal Health
Major Company Profiles operating in the High Viscosity Tissue Adhesives ... 2020 Research Key Players, Industry Overview by 2026 : Anika Therapeutics, ...
22 Oct 2020
KDMI Latest Report – What is the impact of Coronavirus {COVID -19} on Adhesion Barriers Market Growth and Forecast by 2025
-Anika Therapeutics, Inc. -Baxter. -BD. -Betatech Medical. -FzioMed, Inc. -Innocoll Holdings plc. -Integra LifeSciences Corporation. -MAST Biosurgery USA Inc.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Anika Therapeutics, Inc. | 2.07 | 2.04 | 4.14 | 0 | 0 | 0 | 4.65 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.15 | 100 | 19 | 0 | 0 | 98.93 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.89 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.06 | 100 | 0 | 0 | 90.93 |
Anika Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Anika Therapeutics, Inc. | $114,610 | $51,615 | $27,193 | $513.313M | 46 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.177B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.881B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.867B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.532B | 4 |